These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25361800)

  • 1. Solid malignancies in individuals with Down syndrome: a case presentation and literature review.
    Bratman SV; Horst KC; Carlson RW; Kapp DS
    J Natl Compr Canc Netw; 2014 Nov; 12(11):1537-45. PubMed ID: 25361800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.
    Dey N; Krie A; Klein J; Williams K; McMillan A; Elsey R; Sun Y; Williams C; De P; Leyland-Jones B
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patient with partial trisomy 21 and 7q deletion expresses mild Down syndrome phenotype.
    Papoulidis I; Papageorgiou E; Siomou E; Oikonomidou E; Thomaidis L; Vetro A; Zuffardi O; Liehr T; Manolakos E; Vassilis P
    Gene; 2014 Feb; 536(2):441-3. PubMed ID: 24334122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased low-level chromosome 21 mosaicism in older individuals with Down syndrome.
    Jenkins EC; Schupf N; Genovese M; Ye LL; Kapell D; Canto B; Harris M; Devenny D; Lee JH; Brown WT
    Am J Med Genet; 1997 Jan; 68(2):147-51. PubMed ID: 9028448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid peroxidation in Down syndrome caused by regular trisomy 21, trisomy 21 by Robertsonian translocation and mosaic trisomy 21.
    Casado A; López-Fernández ME; Ruíz R
    Clin Chem Lab Med; 2007; 45(1):59-62. PubMed ID: 17243916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of malignant disorders in individuals with Down's syndrome.
    Hasle H
    Lancet Oncol; 2001 Jul; 2(7):429-36. PubMed ID: 11905737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down syndrome: a study of chromosomal mosaicism.
    Modi D; Berde P; Bhartiya D
    Reprod Biomed Online; 2003 Jun; 6(4):499-503. PubMed ID: 12831601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down syndrome phenotypes: the consequences of chromosomal imbalance.
    Korenberg JR; Chen XN; Schipper R; Sun Z; Gonsky R; Gerwehr S; Carpenter N; Daumer C; Dignan P; Disteche C
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4997-5001. PubMed ID: 8197171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental age and the origin of extra chromosome 21 in Down syndrome.
    Jyothy A; Kumar KS; Mallikarjuna GN; Babu Rao V; Uma Devi B; Sujatha M; Reddy PP
    J Hum Genet; 2001; 46(6):347-50. PubMed ID: 11393539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancy in children with trisomy 21.
    Rabin KR; Whitlock JA
    Oncologist; 2009 Feb; 14(2):164-73. PubMed ID: 19176633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trisomy 21 and Down syndrome: a short review.
    Sommer C; Henrique-Silva F
    Braz J Biol; 2008 May; 68(2):447-52. PubMed ID: 18660978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
    Olson LE; Richtsmeier JT; Leszl J; Reeves RH
    Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of dysregulated microRNAs in lymphocytes from children with Down syndrome.
    Xu Y; Li W; Liu X; Chen H; Tan K; Chen Y; Tu Z; Dai Y
    Gene; 2013 Nov; 530(2):278-86. PubMed ID: 23933415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisomy 21 mosaicism: we may all have a touch of Down syndrome.
    Hultén MA; Jonasson J; Iwarsson E; Uppal P; Vorsanova SG; Yurov YB; Iourov IY
    Cytogenet Genome Res; 2013; 139(3):189-92. PubMed ID: 23306383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningioma in Down Syndrome.
    Yamamoto T; Shinojima N; Todaka T; Nishikawa S; Yano S; Kuratsu J
    World Neurosurg; 2015 Sep; 84(3):866.e1-6. PubMed ID: 25862935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial teratoma in children: the role of chromosome 21 trisomy.
    Ferraz ST; Valera ET; Brassesco MS; Santos de Oliveira R; Carlos dos Santos A; Saggioro FP; Neder L; Scrideli CA; Tone LG
    Neuropathology; 2014 Apr; 34(2):197-200. PubMed ID: 24812702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models of Down syndrome: gene content and consequences.
    Gupta M; Dhanasekaran AR; Gardiner KJ
    Mamm Genome; 2016 Dec; 27(11-12):538-555. PubMed ID: 27538963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trisomy of chromosome 21 in leukemogenesis.
    Izraeli S; Rainis L; Hertzberg L; Smooha G; Birger Y
    Blood Cells Mol Dis; 2007; 39(2):156-9. PubMed ID: 17532652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions of chromosome 21 restricted to the leukemic cells of children with Down syndrome and leukemia.
    Kempski HM; Chessells JM; Reeves BR
    Leukemia; 1997 Nov; 11(11):1973-7. PubMed ID: 9369434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models.
    Mendioroz M; Do C; Jiang X; Liu C; Darbary HK; Lang CF; Lin J; Thomas A; Abu-Amero S; Stanier P; Temkin A; Yale A; Liu MM; Li Y; Salas M; Kerkel K; Capone G; Silverman W; Yu YE; Moore G; Wegiel J; Tycko B
    Genome Biol; 2015 Nov; 16():263. PubMed ID: 26607552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.